GlassScriptUltracor Breast Tissue Marker
Payments companies reported to CMS as associated with Ultracor Breast Tissue Marker. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Ultracor Breast Tissue Marker, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Ultracor Breast Tissue Marker
These are the largest totals companies reported as associated with Ultracor Breast Tissue Marker. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Clark Rogers | Orlando, FL | Diagnostic Radiology | $148.05 |
| Jahnavi Pastore | Burlington, MA | Diagnostic Radiology | $71.49 |
| David Namazy | San Diego, CA | Nephrology (Internal Medicine) | $54.63 |
| Bruce Gearhart | Dayton, OH | Diagnostic Radiology | $40.61 |
| Shannon Steed | Louisville, KY | Diagnostic Radiology | $19.80 |
| Lindsey Fauveau | Baton Rouge, LA | Surgical Oncology | $16.09 |
| Amanda Bethel | Baton Rouge, LA | Family | $16.09 |
| Cecilia Cuntz | Baton Rouge, LA | Surgery | $16.09 |
| Amanda Kwan | Baton Rouge, LA | Surgical | $16.09 |
| Patrick Wright | Lynnwood, WA | Body Imaging | $15.26 |
Prescribed Ultracor Breast Tissue Marker?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.